Contemporary Management of 1–4 Brain Metastases
Brain metastases remain the most common neurologic complication of cancer. With improvement in surveillance and systemic therapy, patients with limited CNS disease are living longer after diagnosis, thus influencing the importance of optimal radiation treatment in order to maximize local control and...
Main Authors: | Sarah M. C. Sittenfeld, John H. Suh, Erin S. Murphy, Jennifer S. Yu, Samuel T. Chao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00385/full |
Similar Items
-
Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
by: Jakob Liermann, et al.
Published: (2020-10-01) -
Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases
by: Balamurugan Vellayappan, et al.
Published: (2018-09-01) -
Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
by: Corinna Fritz, et al.
Published: (2018-11-01) -
Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases
by: Nitesh Rana, et al.
Published: (2017-11-01) -
Preoperative Stereotactic Radiosurgery for Brain Metastases
by: David M. Routman, et al.
Published: (2018-11-01)